Incidence and Risk Factors for New-Onset Diabetes in HIV-Infected Patients
Author(s) -
Stéphane De Wit,
Caroline Sabin,
Rainer Weber,
Signe Westring Worm,
Peter Reiss,
Charles Cazanave,
Wafaa ElSadr,
Antonella d’Arminio Monforte,
Éric Fontas,
Matthew Law,
Nina FriisMøller,
Andrew Phillips
Publication year - 2008
Publication title -
diabetes care
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.636
H-Index - 363
eISSN - 1935-5548
pISSN - 0149-5992
DOI - 10.2337/dc07-2013
Subject(s) - medicine , diabetes mellitus , lipodystrophy , cart , incidence (geometry) , didanosine , cohort study , poisson regression , zidovudine , endocrinology , human immunodeficiency virus (hiv) , viral load , population , immunology , antiretroviral therapy , viral disease , environmental health , mechanical engineering , physics , optics , engineering
The aims of this study were to determine the incidence of diabetes among HIV-infected patients in the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) cohort, to identify demographic, HIV-related, and combination antiretroviral therapy (cART)-related factors associated with the onset of diabetes, and to identify possible mechanisms for any relationships found.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom